Don’t miss the latest developments in business and finance.

Sun Pharma to start 14 brand transfers from Novartis

Mitsubishi Tanabe Pharma Corporation will market and distribute all the 14 brands

Sun Pharma ropes in Mitsubishi Tanabe to distribute products in Japan
BS Reporter New Delhi
Last Updated : Sep 06 2016 | 5:40 PM IST
Sun Pharma on Tuesday announced initiation of a phased transfer of manufacturing and marketing rights in Japan for the 14 prescription brands acquired from Novartis earlier this year.

These brands will be transferred from Novartis Pharma K K to Sun Pharma's subsidiary in Japan beginning October 2016.

Sun Pharma has also signed a strategic distribution alliance with Mitsubishi Tanabe Pharma Corporation for these 14 prescription brands that include drugs for Parkinson's disease, epilepsy, depression and hyper-tension.

Under this alliance, following the transfer of manufacturing & marketing rights to Sun Pharma's subsidiary in Japan, Mitsubishi Tanabe Pharma Corporation will market and distribute all the 14 brands as well as provide information on their proper use to healthcare professionals.

 

Also Read

First Published: Sep 06 2016 | 5:02 PM IST

Next Story